Skip to main content
OpenTrials
Completed

NCT Number: NCT03522675

NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test

The objective of this study is to investigate the potential of NeoMatriXTM Wound Matrix to cause an allergic response to healthy volunteers using a skin prick test.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University at Buffalo Clinical and Translational Research Center

Buffalo, New York, 14203, United States

About this study

Using a minimally invasive skin prick test, the test material, positive control, and negative control are applied to the forearm using a prick test. The test area is observed after 15 minutes, 6 hours, and again at 1-2 days after the initial prick test. The skin will be examined for a reaction such as a wheal and/or a flare, a flare alone is not clinically significant.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy volunteers aged at least 18 years.
  • Completed written informed consent and receive a copy of their executed ICF.
  • Volunteers must be capable of understanding and following directions in English.

Exclusion criteria

  • Pregnancy or lactation;
  • Inadequate or non-existent contraception (women of child bearing potential only);
  • A current skin disease;
  • Heavy alcohol consumption;
  • Current use or history of repeated use of recreational drugs;
  • Recent illness prior to test;
  • Significant past medical history of diseases to potentially effect study results;
  • Current treatment of allergy;
  • A history of multiple drug hypersensitivity;
  • Concurrent medication likely to affect the response to the test articles or confuse the results of the study;
  • Known sensitivity to the test articles;
  • Participation in a repeat insult patch test (RIPT), skin prick test (SPT) or follow-up work within the last month;
  • Sensitization or questionable sensitization in a skin test;
  • Recent immunization.

Treatment and study plan

NeoMatriX Wound MatriX Collagen Dressing

Device

Collagen wound dressing

Primary outcomes

  1. Wheal Formation

    Time frame: 15 minutes

    Wheal formation is defined as a raised, pale, itchy formation (allergic reaction) on the skin's surface. A positive (+) allergic response would be indicated by the NeoMatriXTM Wound Matrix producing a wheal >3 mm of the positive control (histamine).

Other outcomes

  1. Wheal Formation

    Time frame: 6 hrs

    Wheal formation is defined as a raised, pale, itchy formation (allergic reaction) on the skin's surface. A positive (+) allergic response would be indicated by the NeoMatriXTM Wound Matrix producing a wheal >3 mm of the positive control (histamine).

  2. Wheal Formation

    Time frame: 2 days

    Wheal formation is defined as a raised, pale, itchy formation (allergic reaction) on the skin's surface. A positive (+) allergic response would be indicated by the NeoMatriXTM Wound Matrix producing a wheal >3 mm of the positive control (histamine).

Sponsors and collaborators

Lead sponsor

NeXtGen Biologics, Inc.

Industry

Collaborators

  • State University of New York at Buffalo

Registry information

Official study title

Skin Prick Test in Healthy Volunteers of Any Sex, to Investigate the Potential Allergy to NeoMatriXTM Wound Matrix

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
May 11, 2018
Registry last updated
May 31, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.